AAAAAA
Results: 1-25/36
Authors:
TOULON P
BOUTIERE B
HORELLOU MH
TRZECIAK MC
SAMAMA MM
Citation: P. Toulon et al., MONITORING HEPARIN-THERAPY USING ACTIVATED PARTIAL THROMBOPLASTIN TIME - RESULTS OF A MULTICENTER TRIAL ESTABLISHING THE THERAPEUTIC RANGE FOR SILIMAT, A REAGENT WITH HIGH-SENSITIVITY TO HEPARIN, Thrombosis and haemostasis, 80(1), 1998, pp. 104-108
Authors:
ZUBER M
GAUTIER V
DORNON O
MARNET L
MAS JL
TOULON P
Citation: M. Zuber et al., MISSENSE MUTATION IN THE FACTOR-V GENE (FACTOR-V-LEIDEN) AND THE RISKOF CEREBRAL THROMBOEMBOLISM - A CASE-CONTROL STUDY, Thrombosis and haemostasis, 1997, pp. 407-407
Authors:
LEMOINE S
DEMAY Y
TOULON P
Citation: S. Lemoine et al., ESTABLISHING A THERAPEUTIC RANGE FOR HEPARIN-THERAPY USING ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) PERFORMED WITH REAGENTS CONTAINING SYNTHETIC PHOSPHOLIPIDS - SYNTHASIL AND SYNTHAFAX, Thrombosis and haemostasis, 1997, pp. 1151-1151
Authors:
TOULON P
GRIS JC
SALMON D
CANDIA N
SERENI D
SICARD D
SCHVED JF
Citation: P. Toulon et al., ACQUIRED FUNCTIONAL PROTEIN-S DEFICIENCY IS ASSOCIATED WITH A PROTHROMBOTIC STATE IN HIV-INFECTED PATIENTS, Thrombosis and haemostasis, 1997, pp. 1720-1720
Authors:
TOULON P
JACOPIN C
WAGNER C
Citation: P. Toulon et al., PROC GLOBAL - A NEW TEST TO EVALUATE THE PROTEIN-C PROTEIN-S PATHWAY, Thrombosis and haemostasis, 1997, pp. 1722-1722
Authors:
AILLAUD MF
JUHAN I
BAUTERS A
JUDE B
BIRON C
SCHVED JF
PERNOD G
POLACK B
DELAHOUSSE B
FIMBEL B
MARQUESVERDIER A
BRIDEY F
TRUCHAUD F
TROSSAERT M
BIHOUR C
VERGNES C
GRIS JC
DENNINGER MH
DUTRILLAUX F
LORENZINI JL
HOUBOUYAN L
LEQUERREC A
FREYBURGER G
BORG JY
BOINOT C
SULTAN Y
TREZIACK MC
BERRUYER M
GUERIN V
TOULON P
MASSIGNON D
DESCHAMPS A
FAVIER R
ROBERT A
JULIA A
Citation: Mf. Aillaud et al., CLINICAL AND BIOLOGICAL DATA IN 68 SUBJECTS WITH HOMOZYGOUS R506Q MUTATION - FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - PROCARE STUDY, Thrombosis and haemostasis, 1997, pp. 2368-2368
Authors:
BIRON C
SCHVED JF
AILLAUD MF
JUHAN I
BAUTERS A
JUDE B
PERNOD G
POLACK B
BRIDEY F
DEPROST D
BORG JY
SALADIN C
LECAM V
DENNINGER MH
TRUCHAUD F
TROSSAERT M
BOINOT C
SULTAN Y
DELAHOUSSE B
FIMBEL B
GRUEL Y
HOUBOUYAN L
BIHOUR C
VERGNES C
DUTRILLAUX F
LORENZINI JL
JULIA A
DESCHAMPS A
FAVIER R
FREYBURGER G
TREZIACK MC
BERRUYER M
GRIS JC
TOULON P
MARQUESVERDIER A
LEQUERREC A
GUERIN V
MASSIGNON D
Citation: C. Biron et al., CLINICAL AND BIOLOGICAL DATA IN 85-R506Q HOMOZYGOTES - FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - PROCARE STUDY, Blood, 90(10), 1997, pp. 654-654
Authors:
TOULON P
WAGNER C
Citation: P. Toulon et C. Wagner, PROC GLOBAL, A NEW SCREENING ASSAY TO ASSESS THE FUNCTIONALITY OF THEPROTEIN-C PROTEIN-S ANTICOAGULANT PATHWAY - RESULTS OF A MULTICENTER TRIAL IN PATIENTS WITH THROMBOPHILIA, Blood, 90(10), 1997, pp. 664-664
Authors:
GRIS JC
TOULON P
BRUN S
MAUGARD C
SARLAT C
SCHVED JF
BERLAN J
Citation: Jc. Gris et al., THE RELATIONSHIP BETWEEN PLASMA MICROPARTICLES, PROTEIN-S AND ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Thrombosis and haemostasis, 76(1), 1996, pp. 38-45
Authors:
TOULON P
GRIS JC
CANDIA N
SALMON D
SERENI D
SICARD D
SCHVED JF
Citation: P. Toulon et al., ACTIVATION OF COAGULATION AND FIBRINOLYSIS IN HIV-INFECTED PATIENTS, Fibrinolysis, 10, 1996, pp. 59-61
Authors:
ZUBER M
TOULON P
MARNET L
MAS JL
Citation: M. Zuber et al., FACTOR-V LEIDEN MUTATION IN CEREBRAL VENOUS THROMBOSIS, Stroke, 27(10), 1996, pp. 1721-1723
Authors:
TOULON P
GRIS JC
SALMON D
CANDIA N
SERENI D
SICARD D
SCHVED JF
Citation: P. Toulon et al., PROCOAGULANT IMBALANCE IN HIV-INFECTED PATIENTS WITH FUNCTIONAL PROTEIN-S DEFICIENCY, Blood, 88(10), 1996, pp. 3075-3075
Authors:
BIRON C
SCHVED HF
AILLAUD MF
JUHAN I
BAUTERS A
JUDE B
PERNOD G
POLACK B
DELAHOUSSE B
FIMBEL B
MARQUESVERDIER A
BRIDEY F
TRUCHAUD F
TROSSAERT M
BIHOUR C
VERGNES C
GRIS JC
DENNINGER MH
DUTRILLAUX F
LORENZINI JL
HOUBOUYAN L
LEQUERREC A
FREYBURGER G
BORG JY
BOINOT C
SULTAN Y
TREZIACK MC
BERURRIER M
GUERIN V
TOULON P
MASSIGNON D
DESCHAMPS A
FAVIER R
JULIA A
Citation: C. Biron et al., FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - THE PROCARE STUDY, Blood, 88(10), 1996, pp. 685-685
Authors:
TOULON P
ZUBER M
GAUTIER V
DORNON O
MARNET L
MAS JL
Citation: P. Toulon et al., ARG506GLN FACTOR-V MUTATION (FACTOR-V LEIDEN) IN CEREBRAL THROMBOEMBOLISM - A CASE-CONTROL STUDY, Blood, 88(10), 1996, pp. 690-690
Authors:
BLANCHE P
TOULON P
DELABLANCHARDIERE A
SICARD D
Citation: P. Blanche et al., CEREBRAL INFARCTION IN 2 AIDS PATIENTS, La Presse medicale, 24(20), 1995, pp. 937-938
Authors:
TOULON P
BLANCHE P
BACHMEYER C
GORIN I
SERENI D
SICARD D
Citation: P. Toulon et al., ACQUIRED PROTEIN-S DEFICIENCY AND HYPOALBUMINEMIA AS RISK-FACTORS FORTHROMBOSIS IN HIV-INFECTION, Thrombosis and haemostasis, 73(6), 1995, pp. 942-942
Authors:
TOULON P
GRIS JC
CANDIA N
SERENI D
SICARD D
SCHVED JF
Citation: P. Toulon et al., PROCOAGULANT IMBALANCE IN HIV-INFECTED PATIENTS - EVIDENCE FOR A PRETHROMBOTIC STATE, Thrombosis and haemostasis, 73(6), 1995, pp. 947-947
Authors:
TOULON P
FRERE E
BACHMEYER C
CANDIA N
BLANCHE P
SERENI D
SICARD D
Citation: P. Toulon et al., FIBRIN POLYMERIZATION DEFECT IN HIV-INFECTED PATIENTS - EVIDENCE FOR A CRITICAL ROLE OF ALBUMIN IN THE PROLONGATION OF THROMBIN AND REPTILASE CLOTTING TIMES, Thrombosis and haemostasis, 73(3), 1995, pp. 349-355
Authors:
BACHMEYER C
TOULON P
DHOTE R
CHRISTOFOROV B
ZUBER M
MAS JL
Citation: C. Bachmeyer et al., ISCHEMIC STROKE AND ACTIVATED PROTEIN-C RESISTANCE, JAMA, the journal of the American Medical Association, 274(16), 1995, pp. 1266-1266
Authors:
TOULON P
GRIS JC
SALMON D
CANDIA N
SERENI D
SICARD D
SCHVED JF
Citation: P. Toulon et al., ANTIPHOSPHOLIPID ANTIBODIES IN HIV-INFECTED PATIENTS ARE NOT ASSOCIATED WITH A PROTHROMBOTIC STATE, Nouvelle revue francaise d'hematologie, 37, 1995, pp. 97-101
Authors:
GANDRILLE S
AIACH M
ABGRALL JF
ALHENCGELAS M
EMMERICH J
AILLAUD MF
JUHANVAGUE I
BOINOT C
DENNINGER MH
DREYFUS M
DUPUY E
MOLHOSABATIER P
FISCHER AM
FORESTIER F
GOUAULTHEILMANN M
HOUBOUYAN L
HOURDILLE P
JUDE B
MICHAUDMALLET A
DEMOERLOOSE P
REBER G
POMMEREUIL M
REYNAUD J
ROUSSI J
SAMPOL J
SIE P
TOULON P
Citation: S. Gandrille et al., IDENTIFICATION OF MUTATIONS IN 90 OF 121 CONSECUTIVE SYMPTOMATIC FRENCH PATIENTS WITH A TYPE-I PROTEIN-C DEFICIENCY, Blood, 86(7), 1995, pp. 2598-2605
Authors:
TOULON P
ANKRI A
TOURNERIE C
SERENI D
Citation: P. Toulon et al., EFFECT OF GEM-91, A PHOSPHOROTHIOATE OLIGONUCLEOTIDE ON THE COAGULATION SYSTEM RESULTS OF EX-VIVO AND IN-VITRO STUDIES, Blood, 86(10), 1995, pp. 3544-3544
Authors:
GANDRILLE S
BORGEL D
ESCHWEGEGUFFLET V
AILLAUD M
DREYFUS M
MATHERON C
GAUSSEM P
ABGRALL JF
JUDE B
SIE P
TOULON P
AIACH M
Citation: S. Gandrille et al., IDENTIFICATION OF 15 DIFFERENT CANDIDATE CAUSAL POINT MUTATIONS AND 3POLYMORPHISMS IN 19 PATIENTS WITH PROTEIN-S DEFICIENCY USING A SCANNING METHOD FOR THE ANALYSIS OF THE PROTEIN-S ACTIVE GENE, Blood, 85(1), 1995, pp. 130-138
Authors:
DHOTE R
BACHMEYER C
HORELLOU MH
TOULON P
CHRISTOFOROV B
Citation: R. Dhote et al., CENTRAL RETINAL VEIN-THROMBOSIS ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C, American journal of ophthalmology, 120(3), 1995, pp. 388-389
Authors:
ROSENCHER N
VASSILIEFF V
TALLET F
TOULON P
LEONI J
TOMENO B
CONSEILLER C
Citation: N. Rosencher et al., COMPARISON OF THE ORTH-EVAC(TM) AND SOLCO TRANS PLUMS(TM) DEVICES FORAUTOTRANSFUSION OF WOUND DRAINAGE AFTER KNEE-JOINT REPLACEMENT SURGERY, Annales francaises d'anesthesie et de reanimation, 13(3), 1994, pp. 318-325